当前位置:首页 - 行情中心 - 华熙生物(688363) - 财务分析 - 现金流量表

华熙生物

(688363)

  

流通市值:281.44亿  总市值:281.44亿
流通股本:4.82亿   总股本:4.82亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,412,552,080.061,167,445,753.715,608,174,664.934,025,359,690.39
  收到的税费返还15,826,940.9210,810,366.7544,017,37642,053,945.58
  收到其他与经营活动有关的现金67,397,801.7228,007,033.85233,135,299.83111,682,057.71
  经营活动现金流入小计2,495,776,822.71,206,263,154.315,885,327,340.764,179,095,693.68
  购买商品、接受劳务支付的现金597,234,503.6338,566,048.691,483,984,780.31,081,574,693.42
  支付给职工以及为职工支付的现金660,268,627.26382,972,583.371,266,864,627.64973,592,048.81
  支付的各项税费161,984,621.6460,877,578.28524,286,123.46411,287,364.43
  支付其他与经营活动有关的现金857,956,812.29446,823,985.262,045,686,675.441,438,585,322.75
  经营活动现金流出小计2,277,444,564.791,229,240,195.65,320,822,206.843,905,039,429.41
  经营活动产生的现金流量净额218,332,257.91-22,977,041.29564,505,133.92274,056,264.27
二、投资活动产生的现金流量:
  取得投资收益收到的现金946,443.22843,818.2232,790,190.3732,441,798.97
  处置固定资产、无形资产和其他长期资产收回的现金净额1,738,491-210,493.38210,493.38
  收到的其他与投资活动有关的现金90,000,00030,000,010.4645,000,000615,000,000
  投资活动现金流入小计92,684,934.2230,843,828.62678,000,683.75647,652,292.35
  购建固定资产、无形资产和其他长期资产支付的现金151,146,165.7395,764,198.81721,388,155.61584,266,420
  投资支付的现金10,910,0006,010,000287,978,213.3269,477,581.24
  支付其他与投资活动有关的现金60,000,000-130,000,000100,000,000
  投资活动现金流出小计222,056,165.73101,774,198.811,139,366,368.91953,744,001.24
  投资活动产生的现金流量净额-129,371,231.51-70,930,370.19-461,365,685.16-306,091,708.89
三、筹资活动产生的现金流量:
  吸收投资收到的现金2,520,000---
  其中:子公司吸收少数股东投资收到的现金2,520,000---
  取得借款收到的现金167,460,125118,460,125149,895,777.78100,000,000
  筹资活动现金流入小计169,980,125118,460,125149,895,777.78100,000,000
  偿还债务支付的现金178,126,119.1858,714,344.88114,181,935.16113,796,608.98
  分配股利、利润或偿付利息支付的现金1,314,312.41641,663.75185,929,313.08185,279,223.37
  其中:子公司支付给少数股东的股利、利润---1,914,024.32
  支付其他与筹资活动有关的现金36,452,054.289,557,578.29160,303,168.45150,624,671.41
  筹资活动现金流出小计215,892,485.8768,913,586.92460,414,416.69449,700,503.76
  筹资活动产生的现金流量净额-45,912,360.8749,546,538.08-310,518,638.91-349,700,503.76
四、汇率变动对现金及现金等价物的影响12,791,476.545,343,906.67,811,616.523,481,744.29
五、现金及现金等价物净增加额55,840,142.07-39,016,966.8-199,567,573.63-378,254,204.09
  加:期初现金及现金等价物余额613,492,408.37613,492,408.37813,059,982813,059,982
  期末现金及现金等价物余额669,332,550.44574,475,441.57613,492,408.37434,805,777.91
补充资料:
  净利润220,803,434.47-168,405,915.37-
  资产减值准备41,390,475.33-159,086,390.37-
  固定资产和投资性房地产折旧135,862,616.19-214,462,756.17-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧135,862,616.19-214,462,756.17-
  无形资产摊销13,262,602.74-24,763,533.21-
  长期待摊费用摊销17,470,579.81-30,182,521.43-
  处置固定资产、无形资产和其他长期资产的损失445,465.9-118,904.82-
  固定资产报废损失865,841.33-856,263.53-
  公允价值变动损失-556,788.66--1,415,364-
  财务费用-8,393,065.66-2,456,846.68-
  投资损失5,773,140.64-12,536,457.12-
  递延所得税15,508,744.11--19,104,001.71-
  其中:递延所得税资产减少15,715,976.84--18,580,934.34-
    递延所得税负债增加-207,232.73--523,067.37-
  存货的减少38,106,528.73--141,486,852.64-
  经营性应收项目的减少-60,123,174.28--86,546,245.42-
  经营性应付项目的增加-258,782,439.7-98,059,596.94-
  其他3,366,403.06-11,541,952.2-
  不涉及现金收支的投资和筹资活动金额其他项目30,171,435.5-158,230,980.63-
  现金的期末余额669,332,550.44-613,492,408.37-
  减:现金的期初余额613,492,408.37-813,059,982-
  现金及现金等价物的净增加额55,840,142.07--199,567,573.63-
公告日期2025-08-272025-04-262025-04-112024-10-31
审计意见(境内)标准无保留意见
TOP↑